SRTA
Strata Critical Medical Inc
3 super-investors hold SRTA worth a combined $32M. The largest position: Daniel Loeb at 1.0% of their portfolio. No cohort buying or selling was filed on the name this quarter. Cohort Conviction Score: 17 — ranked #684 of 724 scored stocks.
Why super-investors own SRTA
Daniel Loeb is the dominant holder in this small cohort, carrying SRTA at 1.0% of his portfolio — a $21M position that accounts for nearly two-thirds of the $32M combined super-investor stake. First Eagle Investment Management and Joel Greenblatt hold token positions that register at 0.0% of their respective portfolios. Activity was entirely static in 2026Q1: no additions, trims, new entrants, or exits. The cohort count has held flat at three owners across the available quarterly history, suggesting neither growing nor fading conviction at the group level. The story here is essentially Loeb's call; the other two owners add breadth but little independent signal.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2025Q3 → 2026Q1How many of the cohort members held this stock each quarter.
Owners (3) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Daniel Loeb | 1.0% | 3q | $21M | 5,000,000 |
| 2 | First Eagle Investment Management | <0.1% | 6q | $9M | 2,266,243 |
| 3 | Joel Greenblatt | <0.1% | 19q | $2M | 372,941 |
Owners of SRTA also hold
Long US equity 13F-HR filings only. CUSIP 092667104. Not investment advice.